Vascular smooth muscle cells from small human omental arteries express P2X1 and P2X4 receptor subunits

Purinergic Signalling

Volumn 10, Issue 4, 2014, Pages 565-572

  Nichols, Claire M ^a   Povstyan, Oleksandr V ^a,b   Albert, Anthony P ^a   Gordienko, Dmitry V ^a,b   Khan, Omar ^c   Vasilikostas, Georgios ^c   Khong, Teck K ^a   Wan, Andrew ^c   Reddy, Marcus ^c   Harhun, Maksym I ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

ATP; Gastro omental arteries; Human; NF279; P2X1 receptor

Indexed keywords

PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X4 RECEPTOR;

ARTERY; BIOSYNTHESIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OMENTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION; WESTERN BLOTTING;

ARTERIES; BLOTTING, WESTERN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; OMENTUM; RECEPTORS, PURINERGIC P2X1; RECEPTORS, PURINERGIC P2X4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOCONSTRICTION;

EID: 84939893559     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-014-9415-6     Document Type: Article

References (36)

1. Bo X, Sexton A, Xiang Z, Nori SL, Burnstock G (1998) Pharmacological and histochemical evidence for P2X receptors in human umbilical vessels. Eur J Pharmacol 353(1):59–65
2. Braun K, Rettinger J, Ganso M, Kassack M, Hildebrandt C, Ullmann H, Nickel P, Schmalzing G, Lambrecht G (2001) NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn Schmiedebergs Arch Pharmacol 364(3):285–290
3. Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509–581
4. Burnstock G (1990) Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl 8(7):S95–S106
5. Burnstock G (1990) Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 17(2):357–368
6. Cario-Toumaniantz C, Loirand G, Ladoux A, Pacaud P (1998) P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83(2):196–203
7. Clifford EE, Parker K, Humphreys BD, Kertesy SB, Dubyak GR (1998) The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Blood 91(9):3172–3181
8. Evans RJ, Surprenant A (1992) Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmacol 106(2):242–249
9. Harhun M, Gordienko D, Kryshtal D, Pucovsky V, Bolton T (2006) Role of intracellular stores in the regulation of rhythmical [Ca(2+)]i changes in interstitial cells of Cajal from rabbit portal vein. Cell Calcium 40(3):287–298
10. Harhun MI, Huggins CL, Ratnasingham K, Raje D, Moss RF, Szewczyk K, Vasilikostas G, Greenwood IA, Khong TK, Wan A, Reddy M (2012) Resident phenotypically modulated vascular smooth muscle cells in healthy human arteries. J Cell Mol Med 16(11):2802–2812
11. Harhun MI, Povstyan OV, Gordienko DV (2010) Purinoreceptor-mediated current in myocytes from renal resistance arteries. Br J Pharmacol 160(4):987–997
12. Harhun MI, Szewczyk K, Laux H, Prestwich SA, Gordienko DV, Moss RF, Bolton TB (2009) Interstitial cells from rat middle cerebral artery belong to smooth muscle cell type. J Cell Mol Med 13(11–12):4532–4539
13. Huggins CL, Povstyan OV, Harhun MI (2013) Characterization of transcriptional and posttranscriptional properties of native and cultured phenotypically modulated vascular smooth muscle cells. Cell Tissue Res 352(2):265–275
14. Hulsmann M, Nickel P, Kassack M, Schmalzing G, Lambrecht G, Markwardt F (2003) NF449, a novel picomolar potency antagonist at human P2X1 receptors. Eur J Pharmacol 470(1–2):1–7
15. Jiang L, Bardini M, Keogh A, dos Remedios CG, Burnstock G (2005) P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. Int J Cardiol 98(2):291–297
16. Lecut C, Frederix K, Johnson DM, Deroanne C, Thiry M, Faccinetto C, Maree R, Evans RJ, Volders PG, Bours V, Oury C (2009) P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J Immunol 183(4):2801–2809
17. Li L, Wu Y, Deng M, Wu G, Ren L (2012) P2X1 receptor-mediated pressor responses in the anesthetized mouse. Acta Pharm Sin B 2(5):459–463
18. Malmsjo M, Hou MF, Pendergast WF, Erlinge DF, Edvinsson L (2003) Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3:4
19. Mulvany MJ, Aalkjaer C (1990) Structure and function of small arteries. Physiol Rev 70(4):921–961
20. Nichols CM, Povstyan OV, Khan O, Vasilikostas G, Khong TK, Wan A, Reddy M, Harhun MI (2013) Molecular identification of P2X receptors in human arteries. Proc 37th IUPS, PCA407
21. Nicke A, Kerschensteiner D, Soto F (2005) Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J Neurochem 92(4):925–933
22. Nicke A, Rettinger J, Schmalzing G (2003) Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers. Mol Pharmacol 63(1):243–252
23. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013–1067
24. Osmond DA, Inscho EW (2010) P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo. Am J Physiol Renal Physiol 298(6):F1360–F1368
25. Pakdeechote P, Rummery NM, Ralevic V, Dunn WR (2007) Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. Eur J Pharmacol 563(1–3):180–186
26. Povstyan OV, Harhun MI, Gordienko DV (2011) Ca(2+) entry following P2X receptor activation induces IP(3) receptor-mediated Ca(2+) release in myocytes from small renal arteries. Br J Pharmacol 162(7):1618–1638
27. Povstyan OV, Nichols CM, Harhun MI (2013) Identification of functional P2X receptors in rat middle cerebral arteries. Proc 37th IUPS PCA395-
28. Ralevic V (2012) P2X receptors in the cardiovascular system. WIREs Membr Transp Signal 1(5):663–674
29. Rettinger J, Schmalzing G, Damer S, Muller G, Nickel P, Lambrecht G (2000) The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor. Neuropharmacology 39(11):2044–2053
30. Rummery NM, Brock JA, Pakdeechote P, Ralevic V, Dunn WR (2007) ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure. J Physiol 582(Pt 2):745–754
31. Somlyo AP (1985) Excitation-contraction coupling and the ultrastructure of smooth muscle. Circ Res 57(4):497–507
32. Soto F, Garcia-Guzman M, Gomez-Hernandez JM, Hollmann M, Karschin C, Stuhmer W (1996) P2X4: an ATP-activated ionotropic receptor cloned from rat brain. Proc Natl Acad Sci U S A 93(8):3684–3688
33. Torres GE, Egan TM, Voigt MM (1999) Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 274(10):6653–6659
34. Valdecantos P, Briones R, Moya P, Germain A, Huidobro-Toro JP (2003) Pharmacological identification of P2X1, P2X4 and P2X7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels. Placenta 24(1):17–26
35. Wallis SJ, Firth J, Dunn WR (1996) Pressure-induced myogenic responses in human isolated cerebral resistance arteries. Stroke 27(12):2287–2290
36. Zsembery A, Boyce AT, Liang L, Peti-Peterdi J, Bell PD, Schwiebert EM (2003) Sustained calcium entry through P2X nucleotide receptor channels in human airway epithelial cells. J Biol Chem 278(15):13398–13408